Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of molecular tests in acute myelogenous leukemia treatment decisions.

Current hematologic malignancy reports - 1 Apr 2010

Motyckova Gabriela, Stone Richard M

Abstract excerpt

The prognosis for patients with acute myelogenous leukemia (AML) is dependent on age, karyotype, and the genetics of the neoplastic cell. The molecular markers with prognostic impact include mutations in FLT3, NPM1, MLL, WT1, c-KIT, and expression levels of BAALC, NM1, ERG, and CXCR4. Gene expression profiles and microRNA expression patterns in AML may prove highly useful in defining the prognosis of AML....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Biomarkers, Tumor
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Karyotyping

Share to Leukemia, Myeloid

Share to MicroRNAs

Share to Nucleophosmin

Share to Prognosis

Source

Identifiers

PMID: 20425404
DOI: 10.1007/s11899-010-0049-7

Genes

BAALC
CXCR4
ERG
FLT3
KIT
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of molecular tests in acute myelogenous leukemia treatment decisions.PMID 20425404Read ↗

Molecular Genetic Markers in Acute Myeloid LeukemiaSemantic proximity Read ↗

Molecular therapy for acute myeloid leukaemia.Semantic proximity Read ↗

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?Semantic proximity Read ↗

Identifying prognostic gene panels in acute myeloid leukemia.Semantic proximity Read ↗

Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic StrategiesSemantic proximity Read ↗

Prognosis and treatment in acute myeloid leukemia: a comprehensive reviewSemantic proximity Read ↗

Clinical implications of molecular markers in acute myeloid leukemia.Semantic proximity Read ↗

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matterSemantic proximity Read ↗

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matterSemantic proximity Read ↗

Acute myeloid leukaemia: How to combine multiple tools.Semantic proximity Read ↗

Molecular diagnosis of acute myeloid leukemia.Semantic proximity Read ↗

Molecular markers in acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.